Literature DB >> 22350390

[Protein glycation as a pathological mechanism in diabetes].

A Simm1, A Navarrete-Santos, B Hofmann, H Bushnaq, N Nass.   

Abstract

The incidence of diabetes has increased in the recent years. Diabetes is characterized by increased sugar concentrations in the blood. Due to this dysregulation, more carbohydrate-induced modification of proteins - so-called advanced glycation end products (AGEs) - are formed endogenously by non-enzymatic reactions. These are discussed to be at least in part responsible for diabetes-associated diseases. The accumulation of AGEs in the tissue can be used as a biomarker for patient outcome. In contrast, the effects of the uptake of AGEs from nutrition are still unclear.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350390     DOI: 10.1007/s00391-011-0282-2

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  53 in total

1.  Retinopathy in diabetes.

Authors:  Donald S Fong; Lloyd Aiello; Thomas W Gardner; George L King; George Blankenship; Jerry D Cavallerano; Fredrick L Ferris; Ronald Klein
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Effect of a single AGE modification on the structure and chaperone activity of human alphaB-crystallin.

Authors:  Jaya Bhattacharyya; Ekaterina V Shipova; Puttur Santhoshkumar; K Krishna Sharma; Beryl J Ortwerth
Journal:  Biochemistry       Date:  2007-11-21       Impact factor: 3.162

3.  Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats.

Authors:  M Ino-ue; N Ohgiya; M Yamamoto
Journal:  Brain Res       Date:  1998-08-03       Impact factor: 3.252

4.  RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.

Authors:  Khin-Mar Myint; Yasuhiko Yamamoto; Toshio Doi; Ichiro Kato; Ai Harashima; Hideto Yonekura; Takuo Watanabe; Harumichi Shinohara; Masayoshi Takeuchi; Koichi Tsuneyama; Noriyoshi Hashimoto; Masahide Asano; Shin Takasawa; Hiroshi Okamoto; Hiroshi Yamamoto
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

5.  Renoprotective effects of a novel inhibitor of advanced glycation.

Authors:  J M Forbes; T Soulis; V Thallas; S Panagiotopoulos; D M Long; S Vasan; D Wagle; G Jerums; M E Cooper
Journal:  Diabetologia       Date:  2001-01       Impact factor: 10.122

6.  Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats.

Authors:  A-S Chen; T Taguchi; M Sugiura; Y Wakasugi; A Kamei; M-W Wang; I Miwa
Journal:  Horm Metab Res       Date:  2004-03       Impact factor: 2.936

7.  Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits.

Authors:  H Vlassara; H Fuh; T Donnelly; M Cybulsky
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

8.  Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle.

Authors:  Jacob M Haus; John A Carrithers; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2007-09-27

9.  Reaction of monosaccharides with proteins: possible evolutionary significance.

Authors:  H F Bunn; P J Higgins
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

Review 10.  Cellular signaling and potential new treatment targets in diabetic retinopathy.

Authors:  Zia A Khan; Subrata Chakrabarti
Journal:  Exp Diabetes Res       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.